CAMP Q1 2020 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$87M+3.3% YoY

Gross Profit

$33M38.2% margin

Operating Income

-$25M-28.6% margin

Net Income

-$56M-64.0% margin

EPS (Diluted)

$-1.65

QoQ Revenue Growth

-9.7%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$496M

Total Liabilities

$358M

Stockholders' Equity

$138M

Cash & Equivalents

$107M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$84M	+3.3%
Gross Profit	$33M	$33M	-0.4%
Operating Income	-$25M	$15M	-261.8%
Net Income	-$56M	$11M	-595.7%

Revenue Segments

Telematics Systems

$52M60%

Software And Subscription Services

$35M40%

Geographic Segments

UNITED STATES

$65M81%

E M E A

$14M17%

Asia Pacific

$2M2%